Filed: 5/16/2023ACC: 0001609251-23-000003
📋 What this filing means
KRENSAVAGE ASSET MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $329.3K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$329.3K
Total AUM (reported)
7.57M
Total Shares
Allocation by class
COM$329.3K100.0%
Portfolio Concentration
Top 3$143.4K43.5%
4–10$180.6K54.8%
11–25$5.3K1.6%
Top 3 weight
43.5%
Top 10 weight
98.4%
Voting Authority Distribution
Total shares with voting rights: 7.57M
Sole
Full voting authority
7.57M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
BIOGEN INC
SOLEShares177.13K
TypeSH
Market value$49.2K
14.96%
Sole
177.13K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares59.49K
TypeSH
Market value$48.9K
14.84%
Sole
59.49K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP
SOLEShares202.11K
TypeSH
Market value$45.3K
13.75%
Sole
202.11K
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares2.14M
TypeSH
Market value$41.5K
12.59%
Sole
2.14M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares1.40M
TypeSH
Market value$39.3K
11.95%
Sole
1.40M
Shared
0.00
None
0.00
EMBECTA CORP
SOLEShares1.06M
TypeSH
Market value$29.9K
9.07%
Sole
1.06M
Shared
0.00
None
0.00
CARDINAL HEALTH INC
SOLEShares353.28K
TypeSH
Market value$26.7K
8.10%
Sole
353.28K
Shared
0.00
None
0.00
ENANTA PHARMACEUTICALS INC
SOLEShares603.30K
TypeSH
Market value$24.4K
7.41%
Sole
603.30K
Shared
0.00
None
0.00
TARO PHARMACEUTICAL INDUS
SOLEShares641.91K
TypeSH
Market value$15.6K
4.74%
Sole
641.91K
Shared
0.00
None
0.00
EAGLE PHARMACEUTICALS INC
SOLEShares113.74K
TypeSH
Market value$3.2K
0.98%
Sole
113.74K
Shared
0.00
None
0.00
KODIAK SCIENCES INC
SOLEShares459.49K
TypeSH
Market value$2.8K
0.87%
Sole
459.49K
Shared
0.00
None
0.00
VANDA PHARMACEUTICALS INC
SOLEShares361.56K
TypeSH
Market value$2.5K
0.75%
Sole
361.56K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOGEN INCSOLE | COM | 177.13K | SH | $49.2K 14.96% | 177.13K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 59.49K | SH | $48.9K 14.84% | 59.49K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORPSOLE | COM | 202.11K | SH | $45.3K 13.75% | 202.11K | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 2.14M | SH | $41.5K 12.59% | 2.14M | 0.00 | 0.00 |
ALKERMES PLCSOLE | COM | 1.40M | SH | $39.3K 11.95% | 1.40M | 0.00 | 0.00 |
EMBECTA CORPSOLE | COM | 1.06M | SH | $29.9K 9.07% | 1.06M | 0.00 | 0.00 |
CARDINAL HEALTH INCSOLE | COM | 353.28K | SH | $26.7K 8.10% | 353.28K | 0.00 | 0.00 |
ENANTA PHARMACEUTICALS INCSOLE | COM | 603.30K | SH | $24.4K 7.41% | 603.30K | 0.00 | 0.00 |
TARO PHARMACEUTICAL INDUSSOLE | COM | 641.91K | SH | $15.6K 4.74% | 641.91K | 0.00 | 0.00 |
EAGLE PHARMACEUTICALS INCSOLE | COM | 113.74K | SH | $3.2K 0.98% | 113.74K | 0.00 | 0.00 |
KODIAK SCIENCES INCSOLE | COM | 459.49K | SH | $2.8K 0.87% | 459.49K | 0.00 | 0.00 |
VANDA PHARMACEUTICALS INCSOLE | COM | 361.56K | SH | $2.5K 0.75% | 361.56K | 0.00 | 0.00 |